1. Home
  2. CURX vs UGRO Comparison

CURX vs UGRO Comparison

Compare CURX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CURX

Curanex Pharmaceuticals Inc

N/A

Current Price

$0.45

Market Cap

14.5M

Sector

Health Care

ML Signal

N/A

Logo urban-gro Inc.

UGRO

urban-gro Inc.

BUY

Current Price

$11.32

Market Cap

13.2M

ML Signal

BUY

Company Overview

Basic Information
Metric
CURX
UGRO
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
13.2M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
CURX
UGRO
Price
$0.45
$11.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
192.0K
11.0M
Earning Date
09-09-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$17,399,438.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.11
52 Week High
$9.18
$39.68

Technical Indicators

Market Signals
Indicator
CURX
UGRO
Relative Strength Index (RSI) 50.62 46.99
Support Level $0.38 $0.74
Resistance Level $0.53 $39.68
Average True Range (ATR) 0.06 3.92
MACD -0.01 -1.43
Stochastic Oscillator 33.93 1.45

Price Performance

Historical Comparison
CURX
UGRO

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: